6550--Reagents and consumables for Oncology
Closed Pre-Solicitation Posted
- Solicitation number
- 36C26226Q0227
- Agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Department of Veterans Affairs VA Greater Los Angeles Healthcare System Los Angeles CA 90073, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Integrated Service Network 22 (VISN 22) is seeking sources for reagents and consumables for oncology applications to support the VA Greater Los Angeles Healthcare System. The procurement targets in-vitro diagnostic substances and laboratory supplies specifically compatible with Ion Torrent S5, Ion Torrent Chef System, and Ion Torrent Genexus platforms, including Oncomine Precision Assay kits, sequencing kits, assay materials, and related consumables. Prospective vendors must be authorized resellers, distributors, or dealers of Original Equipment Manufacturers (OEMs), with no remanufactured or gray market items acceptable. The procurement is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) with a small business size standard of 1,250 employees, and respondents should provide evidence of their business type (such as SDVOSB or VOSB status if applicable), manufacturing or distribution capabilities, existing federal contract holdings, and ability to meet salient characteristics of required products. The Request for Information (RFI) response deadline is January 2, 2026 at 9:00 AM Pacific Time, with submissions directed to Carlos Magana at Carlos.Magana@va.gov, referencing solicitation number 36C26226Q0227.
No set-aside designation has been applied to this procurement opportunity, and no incumbent contractor information is provided in the pre-solicitation materials. The solicitation specifies a line-item list of 24 distinct products from Thermo Fisher Scientific, each with associated manufacturer part numbers and required quantities as detailed in Attachment A, with comprehensive specifications outlined in the Statement of Work. While specific award values or budget ranges are not disclosed in the pre-solicitation documentation, the scope encompasses molecular oncology testing supplies designed to identify 69 specific genes across myeloid and solid tumor categories, including genes such as ABL1, BRAF, KRAS, TP53, and AKT1. Vendor requirements include adherence to strict information security protocols, compliance with federal regulations, and completion of background investigations for any personnel who will access VA computer systems. The contract will be executed through VISN 22's Network Contracting Office in Long Beach, California, with operations during standard federal hours of 7:30 AM to 5:00 PM, Monday through Friday, excluding federal holidays.
Notice text
***View attachments for details***
Files
| File | Type | Posted |
|---|---|---|
| SOW.docx | DOCX document | |
| 36C26226Q0227.docx | DOCX document | |
| RFI Doc.docx | DOCX document | |
| Attachment A.xlsx | XLSX spreadsheet |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside | |
| Q301--NEW – STX Specialized Molecular Residual Disease Testing | Veterans Integrated Service Network 17 | No set-aside | |
| 6550--VISN 4 Coagulation Testing | Veterans Integrated Service Network 4 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity